The role of soluble CD40L in autoimmune diseases
Authors:
Open Access
- 19 April 2025
- journal article
- review article
- Published by Elsevier in Journal of Translational Autoimmunity
- Vol. 10, 100288
Abstract
No abstract availableKeywords
Funding Information
- Centre National pour la Recherche Scientifique et Technique
This publication has 105 references indexed in Scilit:
- Proinflammatory Adaptive Cytokine and Shed Tumor Necrosis Factor Receptor Levels Are Elevated Preceding Systemic Lupus Erythematosus Disease FlareArthritis & Rheumatology, 2014
- Augmented production of chemokines by the interaction of type II collagen–reactive T cells with rheumatoid synovial fibroblastsArthritis & Rheumatism, 2004
- Effector function of type II collagen–stimulated T cells from rheumatoid arthritis patients: Cross‐talk between T cells and synovial fibroblastsArthritis & Rheumatism, 2004
- Distinct mechanisms of action of anti‐CD154 in early versus late treatment of murine lupus nephritisArthritis & Rheumatism, 2003
- A short course of BG9588 (anti–CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritisArthritis & Rheumatism, 2003
- Effects of anti‐CD154 treatment on B cells in murine systemic lupus erythematosusArthritis & Rheumatism, 2003
- Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti‐CD154: A randomized, double‐blind, placebo‐controlled trialArthritis & Rheumatism, 2002
- The role of CD40 ligand and tumor necrosis factor α signaling in the transgenic K/BxN mouse model of rheumatoid arthritisArthritis & Rheumatism, 2000
- Differential regulation of rheumatoid synovial cell interleukin-12 production by tumor necrosis factor ? and CD40 signalsArthritis & Rheumatism, 1999
- Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus seraArthritis & Rheumatism, 1999